Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma
Luca Ceriani(St Thomas' Hospital), Emanuele Zucca(Università della Svizzera italiana), Maria Giuseppina Cabras(University of Cagliari), Stefano Luminari(University of Modena and Reggio Emilia), Donato Mannina(Azienda Ospedaliera Ospedali Riuniti Papardo Piemonte), Eleonora Russo(Sapienza University of Rome), Anastasios Stathis(Princess Margaret Cancer Centre), Caterina Stelitano(University of Reggio Calabria), Franco Cavalli(Institute of Social and Preventive Medicine), Luca Giovanella(University of Zurich), Maurizio Martelli(University of Milan), Francesco Merli(Azienda Sanitaria Unità Locale di Reggio Emilia), Barbara Botto(Palmetto Hematology Oncology), Livio Gargantini, Andrés J.M. Ferreri(Vita-Salute San Raffaele University), Luigi Rigacci(Azienda Ospedaliero-Universitaria Careggi), Pier Luigi Zinzani(Istituto di Ematologia di Bologna), Manuel Gotti(Policlinico San Matteo Fondazione), Graziella Pinotti(Medica (Italy)), Peter Johnson(Cancer Research UK)
Cited by 177
Related Papers
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
|New England Journal of Medicine|2014|1.1k
Advanced pancreatic carcinoma: current treatment and future challenges
|Nature Reviews Clinical Oncology|2010|791
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751